JPRN-UMIN000001588已完成未知
An open-label, multicenter, randomized, controlled, parallel-group comparative study on the effectiveness of carbohydrate-counting and calorie-counting as a dietary management in type 2 diabetic patients treated without insulin therapy - Carbohydrate Counting and Calorie Counting study of dietary management in type 2 diabetic patients without insulin therapy (4C study)
4C-study Research Group0 个研究点目标入组 200 人开始时间: 2008年12月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Complication by stage 3B or more severe diabetic nephropathy, or stage 3 or more severe chronic kidney disease (CKD) not associated with diabetes. 2. Malignant or acute disease. 3. Severe liver disease. 4. Decreased pancreatic function due to chronic pancreatitis, etc. 5. Past history of surgery of the gastrointestinal tract or complication by gastrointestinal disease requiring dietary restriction. 6. Heart failure. 7. Pregnant or lactating women 8. Under insulin treatment 9. Under steroid treatment 10. Patient judged to have difficulty in performing dietetics on his/her own due to dementia, etc. 11. Other patients judged unsuitable by the attending physician.
研究者
相似试验
进行中（未招募）
1 期
A randomized, open-label, multicenter, controlled, parallel arm, phase IIIstudy assessing the efficacy and safety of AOP2014 vs. Hydroxyurea inpatients with Polycythemia VeraMedDRA version: 17.1Level: LLTClassification code 10036061Term: Polycythemia veraSystem Organ Class: 100000004864Polycythemia VeraEUCTR2012-005259-18-CZAOP Orphan Pharmaceuticals AG256
进行中（未招募）
1 期
A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia VeraPolycythemia VeraMedDRA version: 17.0Level: LLTClassification code 10036061Term: Polycythemia veraSystem Organ Class: 100000004864EUCTR2012-005259-18-BGAOP Orphan Pharmaceuticals AG256
进行中（未招募）
1 期
A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia VeraPolycythemia VeraMedDRA version: 16.0Level: LLTClassification code 10036061Term: Polycythemia veraSystem Organ Class: 100000004864EUCTR2012-005259-18-SKAOP Orphan Pharmaceuticals AG256
进行中（未招募）
1 期
A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia VeraMedDRA version: 14.1Level: LLTClassification code 10036061Term: Polycythemia veraSystem Organ Class: 100000004864Polycythemia VeraEUCTR2012-005259-18-ESAOP Orphan Pharmaceuticals AG256
进行中（未招募）
1 期
A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia VeraMedDRA version: 18.0Level: LLTClassification code 10036061Term: Polycythemia veraSystem Organ Class: 100000004864Polycythemia VeraEUCTR2012-005259-18-DEAOP Orphan Pharmaceuticals AG256